It has been shown previously that the development of MASLD is associated with impairments of intestinal barrier function and an increased translocation of LPS, resulting in activation of TLR4-dependent signaling cascades in the liver.41 Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.